Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Carolina Wellness News.
Press releases published on June 27, 2025
Zamnesia Launches Seeds for Change to Support Beloved Asheville
EIN Presswire
·
June 27, 2025
ASHEVILLE, NC, UNITED STATES, June 27, 2025 /EINPresswire.com/ -- Zamnesia, a trusted leader in premium cannabis genetics and culture, is proud to announce the launch of Seeds for Change, a philanthropic initiative dedicated to raising funds for Beloved …
RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening
GlobeNewswire
·
June 27, 2025
APOLLO BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic mapping, and repurposed …
QuietLab Anti-Snoring Mouthpiece Helps Couples Sleep Better and Improve Sleep Health
GlobeNewswire
·
June 27, 2025
New York, USA, June 27, 2025 (GLOBE NEWSWIRE) -- Snoring continues to affect millions of individuals and their partners, often disrupting sleep and straining relationships. Now, QuietLab is addressing this growing issue with its new anti-snoring mouthpiece …
Theranos Makes a Big Bang at the FDA
GlobeNewswire
·
June 27, 2025
PALM BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- Today marks a significant milestone for theranos and its diagnostic technology. The theranos system performs automated sample processing and analysis to produce clinical test results. The U.S. Food and …
INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
·
June 27, 2025
Boca Raton, Florida, June 27, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has entered into securities purchase agreements with two healthcare focused …
Biosimilars Market on the Rise: Expected 19.4% CAGR Over Next Five Years
GlobeNewswire
·
June 27, 2025
Boston, June 27, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Biosimilars: Global Markets” is expected to grow from $28.5 billion in 2024 to $69.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.4% …
New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMA
GlobeNewswire
·
June 27, 2025
New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who transitioned to the investigational higher dose regimen of nusinersen from 12 mg SPINRAZA® (nusinersen) Final results from the landmark …
Safety Shot Completes Acquisition of Yerbae Brands Corp.
GlobeNewswire
·
June 27, 2025
SCOTTSDALE, Ariz., June 27, 2025 (GLOBE NEWSWIRE) -- Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF) (“Yerbaé”), a plant-based energy beverage company, and Safety Shot, Inc. (Nasdaq: SHOT) (“SHOT”, “Safety Shot”, or the “Company”), a wellness and dietary …
Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement
GlobeNewswire
·
June 27, 2025
FREEHOLD, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), an emerging leader in the development of non-opioid pain treatment therapeutics, today announced a 10-for-one reverse …
ALPHA PRO TECH, LTD. ANNOUNCES $2 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM
GlobeNewswire
·
June 27, 2025
NOGALES, Ariz., June 27, 2025 (GLOBE NEWSWIRE) -- – Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today …
Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market
GlobeNewswire
·
June 27, 2025
Vancouver, Canada, June 27, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
VigRX Organic Bio Maca Supplement: Experts Discuss Science Behind Beginner’s Guide to Choose Best Maca Root Supplement For Men & Women
GlobeNewswire
·
June 27, 2025
Limassol, Cyprus, June 27, 2025 (GLOBE NEWSWIRE) -- We live in an extremely fast-paced world which is very competitive and complicated to survive in. We are under pressure constantly be it in our personal life or a professional life. This results in our …
Results of Annual General Meeting
GlobeNewswire
·
June 27, 2025
June 27, 2023 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Results of Annual General Meeting Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment …
Laboratory Information Management System Market worth US$5.19 billion by 2030 with 12.5% CAGR | MarketsandMarkets™.
GlobeNewswire
·
June 27, 2025
Delray Beach, FL, June 27, 2025 (GLOBE NEWSWIRE) -- The global laboratory information management system market, valued at US$2.54 billion in 2024, stood at US$2.88 billion in 2025 and is projected to advance at a resilient CAGR of 12.5% from 2025 to 2030, …
Helius Medical Technologies Announces Reverse Stock Split
GlobeNewswire
·
June 27, 2025
NEWTOWN, Pa., June 27, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced …
Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer
GlobeNewswire
·
June 27, 2025
TARPON SPRINGS, Fla., June 27, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway …
CorMedix Inc. Announces Pricing of Public Offering of Common Stock
GlobeNewswire
·
June 27, 2025
BERKELEY HEIGHTS, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced the pricing of …
Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome
GlobeNewswire
·
June 27, 2025
Phase 3 Aspire study enrollment on track to complete in 2025 Aurora study to evaluate GTX-102 in other Angelman syndrome genotypes and ages expected to initiate later this year NOVATO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc …
Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
June 27, 2025
WATERTOWN, Mass., June 27, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting, anti-inflammatory sinonasal implants for the treatment of chronic …
Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology
GlobeNewswire
·
June 27, 2025
Patent supports the Company’s broader mission to advance minimally invasive, nerve-focused treatments across high-need indications Strengthens strategic position in a multi-billion-dollar market opportunity and expands Autonomix’s growing global IP …